Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2025-12-25 @ 1:34 AM
NCT ID:
NCT05439694
Eligibility Criteria:
Inclusion Criteria:
* o Pregnant women attending for elective CS.
* Women on antenatal anticoagulation ( LMWH , UFH , Fondaparinux ) for conditions such as : Prosthetic Valve , DVT , Pulmonary embolism , Dural sinus thrombosis , AF.
* Pregnant Women with indication for postnatal warfarin anticoagulation( Prosthetic Valve , DVT , Dural Sinus Thrombosis , AF , Pulmonary embolism )
* Age between 20-40 years.
* Pregnancies between 37 and 39 weeks
* BMI between (18.5 - 30.0)
Exclusion Criteria:
* o Pregnancy with risk of obstetric hemorrhage such as abnormally invasive placenta, placenta previa, placental abruption.
* Women with Renal and Hepatic failure
* Women with bleeding diathesis for reasons other than warfarin anticoagulation therapy
* Women with known allergy to Tranexamic acid
* Anemia Hb below 8g/dl
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
40 Years
Study:
NCT05439694
Study Brief:
Protocol Section:
NCT05439694